Indivior to Participate in Upcoming Investor Events
- Jefferies Global Healthcare Conference –
New York City , NY
- Goldman Sachs 46th Annual Global Healthcare Conference –
Miami, FL
- Northland Growth Conference 2025 – Virtual
About Indivior
Indivior is a global pharmaceutical company working to help change patients' lives by developing medicines to treat substance use disorders (SUD). Our vision is that all patients around the world will have access to evidence-based treatment for the chronic conditions and co-occurring disorders of SUD. Indivior is dedicated to transforming SUD from a global human crisis to a recognized and treated chronic disease. Building on its global portfolio of OUD treatments, Indivior has a pipeline of product candidates designed to expand on its heritage in this category. Headquartered in
View original content to download multimedia:https://www.prnewswire.com/news-releases/indivior-to-participate-in-upcoming-investor-events-302453910.html
SOURCE Indivior PLC
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sur-Seal Rebrands as Cohesive Components Following Acquisition by Brodie Generational Capital Partners
- Curavit Expands Clinical Research Capabilities with Acquisition of Lindus Health CRO Assets, Accelerating Global Trial Execution for Life Science Sponsors
- SICC Grants Freezing of Crypto Assets Worth S$75 Million in Transfers Dispute
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Goldman Sachs, Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share